Literature DB >> 11902734

Predictors of outcome in the pediatric intensive care units of children with malignancies.

Ron Ben Abraham1, Amos Toren, Nava Ono, Avi A Weinbroum, Amir Vardi, Zohar Barzilay, Gideon Paret.   

Abstract

PURPOSE: Children with malignancies in whom life-threatening complications develop are traditionally considered as having a grim prognosis. Clinical predictors of short-term outcome for rational triage to pediatric intensive care units (PICU) were retrospectively assessed. PATIENTS AND METHODS: The records of 94 children consecutively admitted to the PICU at the authors' institution between January 1989 and January 1999 were reviewed, and predictors of 30-day mortality rates were delineated using stepwise logistic regression.
RESULTS: The children's mean age was 7.3 years (range, 2-21). Their diseases included hematologic malignancies 45 (48%), extracranial solid tumors 21 (22%), and intracranial tumors 28 (30%). The overall 30-day survival rate was 66%. Mortality was highest among children admitted for respiratory failure (40%). High mortality was also found for those with circulatory collapse (33.3%) and neurologic deterioration (31%). The admitting pediatric risk of mortality score (PRISM) among the survivors was 6.6 +/- 1.3, compared with 15.2 +/- 3 among nonsurvivors (P < 0.01). The number of organ system failures was higher among the nonsurvivors on admission (P < 0.001). The need for ventilatory or inotropic support corresponded to worse outcome (P < 0.001 or P < 0.01, respectively). Overall, 36 (38%) of the children had sepsis during their PICU stay, with a mortality rate of 50% compared with 24% among nonseptic children (P < 0.01). Sepsis present on admission was later correlated with the development of organ system failure (P < 0.01).
CONCLUSIONS: New trends in therapeutic approaches to children with malignancies can clearly improve outcome. The high (66%) survival rate justifies policy of early admission to the PICU of children in whom signs of multiorgan involvement start to develop, as reflected by high PRISM and the need for ventilatory or inotropic support. Further refinement of reliable clinical predictors of survival will enable better triage of these children to the PICU for possible prevention of systemic complications and reduction of mortality rates.

Entities:  

Mesh:

Year:  2002        PMID: 11902734     DOI: 10.1097/00043426-200201000-00007

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  16 in total

1.  Cost-effectiveness of levofloxacin prophylaxis against bacterial infection in pediatric patients with acute myeloid leukemia.

Authors:  Meghan McCormick; Erika Friehling; Ramasubramanian Kalpatthi; Nalyn Siripong; Kenneth Smith
Journal:  Pediatr Blood Cancer       Date:  2020-07-25       Impact factor: 3.167

2.  Comment on "impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with haematological malignancies" by Vandijck et al.

Authors:  Sascha Meyer; Ludwig Gortner; Sven Gottschling
Journal:  Intensive Care Med       Date:  2008-07-18       Impact factor: 17.440

3.  Pediatric cancer type predicts infection rate, need for critical care intervention, and mortality in the pediatric intensive care unit.

Authors:  Matt S Zinter; Steven G DuBois; Aaron Spicer; Katherine Matthay; Anil Sapru
Journal:  Intensive Care Med       Date:  2014-07-15       Impact factor: 17.440

4.  Hospital Variation in Intensive Care Resource Utilization and Mortality in Newly Diagnosed Pediatric Leukemia.

Authors:  Julie C Fitzgerald; Yimei Li; Brian T Fisher; Yuan-Shung Huang; Tamara P Miller; Rochelle Bagatell; Alix E Seif; Richard Aplenc; Neal J Thomas
Journal:  Pediatr Crit Care Med       Date:  2018-06       Impact factor: 3.624

5.  Outcome and prognostic factors seen in pediatric oncology patients admitted in PICU of a developing country.

Authors:  Nida Akhtar; Zehra Fadoo; Sukaina Panju; Anwarul Haque
Journal:  Indian J Pediatr       Date:  2011-03-25       Impact factor: 1.967

6.  Assessing the risk of mortality in paediatric cancer patients admitted to the paediatric intensive care unit: a novel risk score?

Authors:  Sascha Meyer; Sven Gottschling; Tamir Biran; Thomas Georg; Karim Ehlayil; Norbert Graf; Ludwig Gortner
Journal:  Eur J Pediatr       Date:  2005-05-24       Impact factor: 3.183

7.  Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United States.

Authors:  Shannon L Maude; Julie C Fitzgerald; Brian T Fisher; Yimei Li; Yuan-Shung Huang; Kari Torp; Alix E Seif; Marko Kavcic; Dana M Walker; Kateri H Leckerman; Todd J Kilbaugh; Susan R Rheingold; Lillian Sung; Theoklis E Zaoutis; Robert A Berg; Vinay M Nadkarni; Neal J Thomas; Richard Aplenc
Journal:  Pediatr Crit Care Med       Date:  2014-02       Impact factor: 3.624

8.  Hospital charges and length of stay associated with septicemia among children hospitalized for leukemia treatment in the United States.

Authors:  Veerajalandhar Allareddy; Sankeerth Rampa; Veerasathpurush Allareddy
Journal:  World J Pediatr       Date:  2012-08-12       Impact factor: 2.764

9.  Changes in transfusion practice over time in the PICU.

Authors:  Michael D Dallman; Xinggang Liu; Anthony D Harris; John R Hess; Bennett B Edelman; David J Murphy; Giora Netzer
Journal:  Pediatr Crit Care Med       Date:  2013-11       Impact factor: 3.624

10.  The critically-ill pediatric hemato-oncology patient: epidemiology, management, and strategy of transfer to the pediatric intensive care unit.

Authors:  Pierre Demaret; Geraldine Pettersen; Philippe Hubert; Pierre Teira; Guillaume Emeriaud
Journal:  Ann Intensive Care       Date:  2012-06-12       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.